TrialArthritis care & research2023

Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial.

Elizabeth R Volkmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.